BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7831347)

  • 1. Recombinant hemoglobins as blood substitutes: a biotechnology perspective.
    Kumar R
    Proc Soc Exp Biol Med; 1995 Feb; 208(2):150-8. PubMed ID: 7831347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of human hemoglobin in transgenic swine: an approach to a blood substitute.
    O'Donnell JK; Martin MJ; Logan JS; Kumar R
    Cancer Detect Prev; 1993; 17(2):307-12. PubMed ID: 8402717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemically modified and recombinant hemoglobin blood substitutes.
    Snyder SR; Walder JA
    Biotechnology; 1991; 19():101-16. PubMed ID: 1786467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of recombinant hemoglobins for use in transfusion fluids.
    Fronticelli C; Koehler RC
    Crit Care Clin; 2009 Apr; 25(2):357-71, Table of Contents. PubMed ID: 19341913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified hemoglobin blood substitutes: present status and future perspectives.
    Chang TM
    Biotechnol Annu Rev; 1998; 4():75-112. PubMed ID: 9890139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human hemoglobins designed for gene therapy of sickle cell disease.
    McCune SL; Reilly MP; Chomo MJ; Asakura T; Townes TM
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9852-6. PubMed ID: 7937904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transfer of functional properties from bovine hemoglobin to human hemoglobin].
    Baudin V; Kister J; Poyart C; Pagnier J
    Transfus Clin Biol; 1995; 2(6):469-71. PubMed ID: 8646343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxygen therapeutics--current concepts.
    Hill SE
    Can J Anaesth; 2001 Apr; 48(4 Suppl):S32-40. PubMed ID: 11336435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IPR and technological issues regarding a biopharmaceutical formulation hemoglobin.
    Honrao C; Banerjee UC; Bansal P
    Recent Pat Biotechnol; 2008; 2(1):60-7. PubMed ID: 19075854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of artificial cells using nanobiotechnology of hemoglobin based RBC blood substitute as an example.
    Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):551-66. PubMed ID: 17090428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human hemoglobin expression in Escherichia coli: importance of optimal codon usage.
    Hernan RA; Hui HL; Andracki ME; Noble RW; Sligar SG; Walder JA; Walder RY
    Biochemistry; 1992 Sep; 31(36):8619-28. PubMed ID: 1390646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Octamers and nanoparticles as hemoglobin based blood substitutes.
    Baudin-Creuza V; Chauvierre C; Domingues E; Kiger L; Leclerc L; Vasseur C; Célier C; Marden MC
    Biochim Biophys Acta; 2008 Oct; 1784(10):1448-53. PubMed ID: 18342640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant haemoglobin in the development of red-blood-cell substitutes.
    Ogden JE
    Trends Biotechnol; 1992 Mar; 10(3):91-6. PubMed ID: 1367945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial clinical experience with a rationally designed, genetically engineered recombinant human hemoglobin.
    Shoemaker SA; Gerber MJ; Evans GL; Archer-Paik LE; Scoggin CH
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):457-65. PubMed ID: 7994368
    [No Abstract]   [Full Text] [Related]  

  • 15. A hemoglobin-based blood substitute: transplanting a novel allosteric effect of crocodile Hb.
    Komiyama N; Tame J; Nagai K
    Biol Chem; 1996 Sep; 377(9):543-8. PubMed ID: 9067251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development and challenge of modified hemoglobins as red blood cell substitutes].
    Lu XL
    Sheng Wu Gong Cheng Xue Bao; 2006 Jan; 22(1):7-18. PubMed ID: 16572834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemoglobin-based oxygen carriers.
    Stowell CP
    Curr Opin Hematol; 2002 Nov; 9(6):537-43. PubMed ID: 12394179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical protein production by yeast: towards production of human blood proteins by microbial fermentation.
    Martínez JL; Liu L; Petranovic D; Nielsen J
    Curr Opin Biotechnol; 2012 Dec; 23(6):965-71. PubMed ID: 22503236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future prospects for artificial blood.
    Chang TM
    Trends Biotechnol; 1999 Feb; 17(2):61-7. PubMed ID: 10087605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant hemoglobin A produced in transgenic swine: structural equivalence with human hemoglobin A.
    Rao MJ; Schneider K; Chait BT; Chao TL; Keller H; Anderson S; Manjula BN; Kumar R; Acharya AS
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):695-700. PubMed ID: 7994390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.